BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 29355718)

  • 1. Trivalent chromium incorporated in a crystalline calcium phosphate matrix accelerates materials degradation and bone formation in vivo.
    Rentsch B; Bernhardt A; Henß A; Ray S; Rentsch C; Schamel M; Gbureck U; Gelinsky M; Rammelt S; Lode A
    Acta Biomater; 2018 Mar; 69():332-341. PubMed ID: 29355718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cu
    Schamel M; Bernhardt A; Quade M; Würkner C; Gbureck U; Moseke C; Gelinsky M; Lode A
    Mater Sci Eng C Mater Biol Appl; 2017 Apr; 73():99-110. PubMed ID: 28183678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoclastic differentiation and resorption is modulated by bioactive metal ions Co2+, Cu2+ and Cr3+ incorporated into calcium phosphate bone cements.
    Bernhardt A; Schamel M; Gbureck U; Gelinsky M
    PLoS One; 2017; 12(8):e0182109. PubMed ID: 28763481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strontium substitution in apatitic CaP cements effectively attenuates osteoclastic resorption but does not inhibit osteoclastogenesis.
    Schumacher M; Wagner AS; Kokesch-Himmelreich J; Bernhardt A; Rohnke M; Wenisch S; Gelinsky M
    Acta Biomater; 2016 Jun; 37():184-94. PubMed ID: 27084107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone regeneration capacity of magnesium phosphate cements in a large animal model.
    Kanter B; Vikman A; Brückner T; Schamel M; Gbureck U; Ignatius A
    Acta Biomater; 2018 Mar; 69():352-361. PubMed ID: 29409867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eggshell derived brushite bone cement with minimal inflammatory response and higher osteoconductive potential.
    Jayasree R; Kumar TSS; Venkateswari R; Nankar RP; Doble M
    J Mater Sci Mater Med; 2019 Oct; 30(10):113. PubMed ID: 31583477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass spectrometric monitoring of Sr-enriched bone cements--from in vitro to in vivo.
    Rohnke M; Henss A; Kokesch-Himmelreich J; Schumacher M; Ray S; Alt V; Gelinsky M; Janek J
    Anal Bioanal Chem; 2013 Nov; 405(27):8769-80. PubMed ID: 24026517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone formation induced by strontium modified calcium phosphate cement in critical-size metaphyseal fracture defects in ovariectomized rats.
    Thormann U; Ray S; Sommer U; Elkhassawna T; Rehling T; Hundgeburth M; Henß A; Rohnke M; Janek J; Lips KS; Heiss C; Schlewitz G; Szalay G; Schumacher M; Gelinsky M; Schnettler R; Alt V
    Biomaterials; 2013 Nov; 34(34):8589-98. PubMed ID: 23906515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated bone regeneration through rational design of magnesium phosphate cements.
    Kaiser F; Schröter L; Stein S; Krüger B; Weichhold J; Stahlhut P; Ignatius A; Gbureck U
    Acta Biomater; 2022 Jun; 145():358-371. PubMed ID: 35443213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of processing conditions of dicalcium phosphate cements on graft resorption and bone formation.
    Sheikh Z; Zhang YL; Tamimi F; Barralet J
    Acta Biomater; 2017 Apr; 53():526-535. PubMed ID: 28213100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Data on TOF-SIMS analysis of Cu
    Henß A; Schamel M; Gbureck U; Gelinsky M; Lode A
    Data Brief; 2017 Aug; 13():353-355. PubMed ID: 28664170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporation of chitosan-alginate complex into injectable calcium phosphate cement system as a bone graft material.
    Lee HJ; Kim B; Padalhin AR; Lee BT
    Mater Sci Eng C Mater Biol Appl; 2019 Jan; 94():385-392. PubMed ID: 30423721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gold is for the mistress, silver for the maid: Enhanced mechanical properties, osteoinduction and antibacterial activity due to iron doping of tricalcium phosphate bone cements.
    Uskoković V; Graziani V; Wu VM; Fadeeva IV; Fomin AS; Presniakov IA; Fosca M; Ortenzi M; Caminiti R; Rau JV
    Mater Sci Eng C Mater Biol Appl; 2019 Jan; 94():798-810. PubMed ID: 30423766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological responses of brushite-forming Zn- and ZnSr- substituted beta-tricalcium phosphate bone cements.
    Pina S; Vieira SI; Rego P; Torres PM; da Cruz e Silva OA; da Cruz e Silva EF; Ferreira JM
    Eur Cell Mater; 2010 Sep; 20():162-77. PubMed ID: 20821372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substitutions of strontium in bioactive calcium silicate bone cements stimulate osteogenic differentiation in human mesenchymal stem cells.
    Huang TH; Kao CT; Shen YF; Lin YT; Liu YT; Yen SY; Ho CC
    J Mater Sci Mater Med; 2019 Jun; 30(6):68. PubMed ID: 31165270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly bioactive bone cement microspheres based on α-tricalcium phosphate microparticles/mesoporous bioactive glass nanoparticles: Formulation, physico-chemical characterization and in vivo bone regeneration.
    El-Fiqi A; Kim JH; Kim HW
    Colloids Surf B Biointerfaces; 2022 Sep; 217():112650. PubMed ID: 35763895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel strontium(II)-modified calcium phosphate bone cement stimulates human-bone-marrow-derived mesenchymal stem cell proliferation and osteogenic differentiation in vitro.
    Schumacher M; Lode A; Helth A; Gelinsky M
    Acta Biomater; 2013 Dec; 9(12):9547-57. PubMed ID: 23917042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zinc-doped calcium silicate additive accelerates early angiogenesis and bone regeneration of calcium phosphate cement by double bioactive ions stimulation and immunoregulation.
    Lu T; Wang J; Yuan X; Tang C; Wang X; He F; Ye J
    Biomater Adv; 2022 Oct; 141():213120. PubMed ID: 36122428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologically mediated resorption of brushite cement in vitro.
    Grover LM; Gbureck U; Wright AJ; Tremayne M; Barralet JE
    Biomaterials; 2006 Apr; 27(10):2178-85. PubMed ID: 16337265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strontium-modified premixed calcium phosphate cements for the therapy of osteoporotic bone defects.
    Lode A; Heiss C; Knapp G; Thomas J; Nies B; Gelinsky M; Schumacher M
    Acta Biomater; 2018 Jan; 65():475-485. PubMed ID: 29107056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.